R. Andrew Eckert

Andy Eckert has held a number of senior executive positions during his career. He is currently the CEO of Acelity L.P., Inc., a global advanced wound care company. Prior to Acelity, Andy was the CEO of Valence Health, an emerging leader in value-based healthcare, which was acquired by Evolent Health in 2016. Prior to that he was CEO of TriZetto, a leader in Payer IT. Apax Partners sold TriZetto to Cognizant Technology Solutions Corporation in 2014 for $2.7B. Prior to TriZetto, Andy was Chairman and CEO of CRC Health Group, the leading behavioral health treatment provider owned by Bain Capital. CRC was sold to Acadia Healthcare in 2015 for $1.3B. Earlier in his career, Andy was CEO of Eclipsys Corporation ($500M HCIT company) from 2005-2009 and CEO of SumTotal Systems (e-learning) from 2002-2005. He started his career at ADAC Laboratories, a leader in Nuclear Medicine, PET and clinical IT where he spent 11 years, including 4 as Chairman and CEO until its sale to Philips Medical Systems in 2000.

Andy has served on a number of corporate boards. He is currently the Chairman of Varian Medical Systems and a member of the board of directors of Becton, Dickinson & Company.